Efficacy and safety of anti-epidermal growth factor receptor therapy compared with anti-vascular endothelial growth factor therapy for metastatic colorectal cancer in first-line and second-line therapies: a meta-analysis

AIM: This study aimed to compare anti-epidermal growth factor receptor (anti-EGFR) therapy and anti-vascular endothelial growth factor therapy as first-line and second-line therapies in patients with KRAS exon 2 codon 12/13 wild-type (KRAS-WT) metastatic colorectal cancer (mCRC). METHODS: Major data...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongchi, Ma, Bin, Gao, Peng, Song, Yongxi, Xu, Qingzhou, Hu, Yaoyuan, Zhang, Cong, Wang, Zhenning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012842/
https://www.ncbi.nlm.nih.gov/pubmed/27621654
http://dx.doi.org/10.2147/OTT.S111240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012842/
https://www.ncbi.nlm.nih.gov/pubmed/27621654
http://dx.doi.org/10.2147/OTT.S111240

Ejemplares similares